NDC 51662-1220
DOPAMINE HCI
Dopamine Hci
DOPAMINE HCI is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co. Llc, Dba Health First. The primary component is Dopamine Hydrochloride.
Product ID | 51662-1220_74205252-394a-57fa-e053-2991aa0aee4d |
NDC | 51662-1220 |
Product Type | Human Prescription Drug |
Proprietary Name | DOPAMINE HCI |
Generic Name | Dopamine Hci |
Dosage Form | Injection, Solution, Concentrate |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2018-08-23 |
Marketing Category | NDA / NDA |
Application Number | NDA018132 |
Labeler Name | HF Acquisition Co. LLC, DBA Health First |
Substance Name | DOPAMINE HYDROCHLORIDE |
Active Ingredient Strength | 40 mg/mL |
Pharm Classes | Catecholamine [EPC],Catecholamines [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |